New Oxygen Technology released its second quarter 2022 financial report. According to the financial report, the company’s total revenue in the second quarter was 309.1 million yuan (about 46.1 million US dollars), a decrease of 31.6% compared with 451.8 million yuan in the same period last year. Net loss attributable to New Oxygen Technology was 32.3 million yuan ($4.8 million), compared with a net profit of 57.6 million yuan a year earlier. Non-GAAP net loss attributable to New Oxygen Technology was 22.7 million yuan (approximately US$3.4 million), compared with a net profit of 73.7 million yuan in the same period last year.
In the second quarter, New Oxygen’s average mobile monthly active users (MAU) was 35.4 million, compared to 10 million in the same period in 2021. The number of paid medical service providers on the New Oxygen Technology platform was 5,735, an increase of 17.1% from 4,899 in the same period last year. The number of medical service providers that subscribed to information services on the Xinxing Technology platform was 2,622, compared to 2,236 in the second quarter of 2021. The total number of users who purchased appointment services was 129,500, compared to 244,800 in the second quarter of 2021.
New Oxygen Technology expects revenue in the third quarter of 2022 to reach 310 million yuan (about 46.3 million yuan) to 330 million yuan (about 49.3 million US dollars), a year-on-year decline of 28.1% to 23.5%.
media coverage
TechWeb Dynamic Technology Titanium Media
event tracking
- 2022-08-17 After reading the new oxygen financial report, I almost thought that the cosmetic surgery business was going to go bankrupt
- 2022-04-29New oxygen starts layoffs
- 2022-03-25The total revenue of New Oxygen Technology in 2021 is 1.69 billion yuan, a year-on-year increase of 30.7%
- 2021-11-19New Oxygen Technology’s revenue in the third quarter was 431.5 million yuan, a year-on-year increase of 20%
- 2021-10-09 Xinxing responds to being sued by many stars: is actively communicating with relevant parties
This article is reproduced from: https://readhub.cn/topic/8iwZ06689ag
This site is for inclusion only, and the copyright belongs to the original author.